A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.

Status:
Completed

Trial end date:
2005-08-01

Target enrollment:

Participant gender:

To demonstrate the efficacy and safety of aliskiren given to patients with both hypertension and diabetes mellitus

Phase 3

Novartis

Ramipril